IMMUNOREGULATORY cytokines produced by the TH1 subset and by CD8 T lymphocytes appear to brake naturally and sometimes arrest the progress of HIV infection in the early phase. It appears reasonable to assume that a mild and equilibrated stimulation of the immune system may prevent or delay the fatal transition towards the prevalent production of TH2-type cytokines. The problem is how to stimulate the immune system in a physiological fashion. In the last 7 years we have clarified the main mechanisms of action of an unorthodox immunotherapeutic method first used 40 years ago. Optimized autohaemotherapy after a brief exposure of blood to ozone may today afford the trick of reprogramming the immune system to keep HIV at bay. The autohaemotherapeutic procedure is simple, safe, inexpensive and most likely is more effective than conventional approaches.
Introduction
Projections of the magnitude of human immunodeficiency virus (HIV) infection by the end of the century range between 20 On the other hand, great progress has been made in the understanding of HIV pathogenesis 1-4 and recently some immunological characteristics of either long-term non-progressors or/and high-risk seronegative individuals have suggested that cellmediated anti-HIV response, soon after infection, may be crucial for controlling the progression of the disease. 4, 5 More specifically, it appears that CD8 lymphocytes present in long-term survivors may release an as yet unidentified cytokine (momentarily denominated cell antiviral factor or CAF), heat and acid-stable, capable of blocking HIV transcription. 6, 7 There is now some consensus that besides the activity of the hypothetical CAF, a prevalent and persistent production of type-1 cytokines (supported by CD4 TH1 cells) such as interleukin (IL)-2, 12, granulocyte-macrophage colony stimulating factor *Dedicated to the memory of Giovanni Battista Rossi (deceased 20 February, 1994) , who was the main force for the study of HIV infection in Italy.
(GM-CSF) and interferon (IFN)7 56 On the other hand it appears evident that the exposure of a precise volume of blood to a known volume of ozone with a predetermined concentration and for a definite time allows a reliable stoichiometric procedure. For each autohaemotherapeutic treatment we advise collecting 250-300 ml of blood in bags containing 25 IU/ml of calciheparin/ml of blood plus 5 mM Ca"*. The elimination of the commonly used anticoagulant solution of citrate-phosphate-dextrose (CPD) and the addition of 5 mM Ca"* markedly enhances the production of cytokines as reported in detail elsewhere. 49 58,s9 reasons for the lack of toxicity after autohaemotherapy discussed at length elsewhere 4 can be attributed to the physiological-like release of cytokines in various cellular microenvironments after the homing of the reinfused cells. The scheme reported in Fig. 1 (Table 2 ) and the relatively low toxicity most likely inhibited by the body anti-oxidant reservoir. 45 Unfortunately, therapeutic efficacy has been evaluated in most cases in anecdotic fashion and for these various routes it appears impossible to define a 
